Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Myovant Sciences Q3 Sales $100.20M Miss $102.36M Estimate

Author: Benzinga Newsdesk | January 26, 2023 05:22pm
Myovant Sciences (NYSE:MYOV) reported quarterly sales of $100.20 million which missed the analyst consensus estimate of $102.36 million by 2.11 percent. This is a 7.17K percent increase over sales of $1.38 million the same period last year.

Posted In: MYOV


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist